Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription Articles published in PLoS Biol Retrieve available abstracts of 58 articles: HTML format

Single Articles

July 2022
1. BUSNADIEGO I, Abela IA, Frey PM, Hofmaenner DA, et al
   Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
   PLoS Biol. 2022;20:e3001709.
   PubMed     Abstract available
   
   
   June 2022
2. GRIFFIN DE
   Why does viral RNA sometimes persist after recovery from acute infections?
   PLoS Biol. 2022;20:e3001687.
   PubMed     Abstract available
   
   
   
3. TAUBE JC, Miller PB, Drake JM
   An open-access database of infectious disease transmission trees to explore superspreader epidemiology.
   PLoS Biol. 2022;20:e3001685.
   PubMed     Abstract available
   
   
   May 2022
4. ZHU DY, Gorman MJ, Yuan D, Yu J, et al
   Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
   PLoS Biol. 2022;20:e3001609.
   PubMed     Abstract available
   
   
   
5. LU-CULLIGAN A, Tabachnikova A, Perez-Then E, Tokuyama M, et al
   No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.
   PLoS Biol. 2022;20:e3001506.
   PubMed     Abstract available
   
   
   
6. SYENINA A, Gan ES, Toh JZN, de Alwis R, et al
   Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
   PLoS Biol. 2022;20:e3001643.
   PubMed     Abstract available
   
   
   
7. RICE BL, Lessler J, McKee C, Metcalf CJE, et al
   Why do some coronaviruses become pandemic threats when others do not?
   PLoS Biol. 2022;20:e3001652.
   PubMed     Abstract available
   
   
   
8. FOLARIN RO, Maina MB, Akinbo AK, Runsewe-Abiodun TI, et al
   Bypassing shortages of personal protective equipment in low-income settings using local production and open source tools.
   PLoS Biol. 2022;20:e3001658.
   PubMed     Abstract available
   
   
   March 2022
9. BESANCON L, Bik E, Heathers J, Meyerowitz-Katz G, et al
   Correction of scientific literature: Too little, too late!
   PLoS Biol. 2022;20:e3001572.
   PubMed     Abstract available
   
   
   
10. JANG KK, Kaczmarek ME, Dallari S, Chen YH, et al
    Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection.
    PLoS Biol. 2022;20:e3001592.
    PubMed     Abstract available
    
    
    February 2022
11. FINCH E, Lowe R, Fischinger S, de St Aubin M, et al
    SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort.
    PLoS Biol. 2022;20:e3001531.
    PubMed     Abstract available
    
    
    
12. BRIERLEY L, Nanni F, Polka JK, Dey G, et al
    Tracking changes between preprint posting and journal publication during a pandemic.
    PLoS Biol. 2022;20:e3001285.
    PubMed     Abstract available
    
    
    December 2021
13. AMANAT F, Strohmeier S, Meade P, Dambrauskas N, et al
    Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.
    PLoS Biol. 2021;19:e3001384.
    PubMed     Abstract available
    
    
    
14. CASTIGLIONE GM, Zhou L, Xu Z, Neiman Z, et al
    Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2.
    PLoS Biol. 2021;19:e3001510.
    PubMed     Abstract available
    
    
    
15. HERDER V, Dee K, Wojtus JK, Epifano I, et al
    Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    PLoS Biol. 2021;19:e3001065.
    PubMed     Abstract available
    
    
    November 2021
16. MURUATO A, Vu MN, Johnson BA, Davis-Gardner ME, et al
    Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
    PLoS Biol. 2021;19:e3001284.
    PubMed     Abstract available
    
    
    October 2021
17. SCANLON AO JE
    Wildlife must be protected from crime and trade for the sake of public and planetary health.
    PLoS Biol. 2021;19:e3001422.
    PubMed     Abstract available
    
    
    
18. JACK A, Ferro LS, Trnka MJ, Wehri E, et al
    SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA.
    PLoS Biol. 2021;19:e3001425.
    PubMed     Abstract available
    
    
    September 2021
19. MOLLENTZE N, Babayan SA, Streicker DG
    Identifying and prioritizing potential human-infecting viruses from their genome sequences.
    PLoS Biol. 2021;19:e3001390.
    PubMed     Abstract available
    
    
    August 2021
20. WANG SY, Takahashi T, Pine AB, Damsky WE, et al
    Challenges in interpreting cytokine data in COVID-19 affect patient care and management.
    PLoS Biol. 2021;19:e3001373.
    PubMed     Abstract available
    
    
    July 2021
21. KISSLER SM, Fauver JR, Mack C, Olesen SW, et al
    Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
    PLoS Biol. 2021;19:e3001333.
    PubMed     Abstract available
    
    
    
22. HOTEZ PJ
    Mounting antiscience aggression in the United States.
    PLoS Biol. 2021;19:e3001369.
    PubMed     Abstract available
    
    
    June 2021
23. HEFFRON AS, McIlwain SJ, Amjadi MF, Baker DA, et al
    The landscape of antibody binding in SARS-CoV-2 infection.
    PLoS Biol. 2021;19:e3001265.
    PubMed     Abstract available
    
    
    
24. NICHOLS JD, Bogich TL, Howerton E, Bjornstad ON, et al
    Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making.
    PLoS Biol. 2021;19:e3001307.
    PubMed     Abstract available
    
    
    May 2021
25. VOGELS CBF, Breban MI, Ott IM, Alpert T, et al
    Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
    PLoS Biol. 2021;19:e3001236.
    PubMed     Abstract available
    
    
    
26. FU D, Zhang G, Wang Y, Zhang Z, et al
    Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes.
    PLoS Biol. 2021;19:e3001209.
    PubMed     Abstract available
    
    
    
27. LOWE-POWER TM, Dyson L, Polter AM
    A generation of junior faculty is at risk from the impacts of COVID-19.
    PLoS Biol. 2021;19:e3001266.
    PubMed     Abstract available
    
    
    April 2021
28. MOGHADAS SM, Vilches TN, Zhang K, Nourbakhsh S, et al
    Evaluation of COVID-19 vaccination strategies with a delayed second dose.
    PLoS Biol. 2021;19:e3001211.
    PubMed     Abstract available
    
    
    
29. FRASER N, Brierley L, Dey G, Polka JK, et al
    The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.
    PLoS Biol. 2021;19:e3000959.
    PubMed     Abstract available
    
    
    
30. GALLAGHER T, McCray PB Jr
    The first few days of a SARS-CoV-2 infection viewed at single-cell resolution.
    PLoS Biol. 2021;19:e3001217.
    PubMed     Abstract available
    
    
    
31. ZHU X, Mannar D, Srivastava SS, Berezuk AM, et al
    Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
    PLoS Biol. 2021;19:e3001237.
    PubMed     Abstract available
    
    
    
32. FERGUSON J, Dunn S, Best A, Mirza J, et al
    Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key.
    PLoS Biol. 2021;19:e3001216.
    PubMed     Abstract available
    
    
    March 2021
33. REVERBY SM
    Racism, disease, and vaccine refusal: People of color are dying for access to COVID-19 vaccines.
    PLoS Biol. 2021;19:e3001167.
    PubMed     Abstract available
    
    
    
34. FULWEILER RW, Davies SW, Biddle JF, Burgin AJ, et al
    Rebuild the Academy: Supporting academic mothers during COVID-19 and beyond.
    PLoS Biol. 2021;19:e3001100.
    PubMed     Abstract available
    
    
    
35. KIM KS, Ejima K, Iwanami S, Fujita Y, et al
    A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
    PLoS Biol. 2021;19:e3001128.
    PubMed     Abstract available
    
    
    
36. MACLEAN OA, Lytras S, Weaver S, Singer JB, et al
    Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.
    PLoS Biol. 2021;19:e3001115.
    PubMed     Abstract available
    
    
    
37. POHL MO, Busnadiego I, Kufner V, Glas I, et al
    SARS-CoV-2 variants reveal features critical for replication in primary human cells.
    PLoS Biol. 2021;19:e3001006.
    PubMed     Abstract available
    
    
    
38. RAVINDRA NG, Alfajaro MM, Gasque V, Huston NC, et al
    Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
    PLoS Biol. 2021;19:e3001143.
    PubMed     Abstract available
    
    
    February 2021
39. RIHN SJ, Merits A, Bakshi S, Turnbull ML, et al
    A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.
    PLoS Biol. 2021;19:e3001091.
    PubMed     Abstract available
    
    
    
40. COMER SP, Cullivan S, Szklanna PB, Weiss L, et al
    COVID-19 induces a hyperactive phenotype in circulating platelets.
    PLoS Biol. 2021;19:e3001109.
    PubMed     Abstract available
    
    
    January 2021
41. HOTEZ PJ
    Anti-science kills: From Soviet embrace of pseudoscience to accelerated attacks on US biomedicine.
    PLoS Biol. 2021;19:e3001068.
    PubMed     Abstract available
    
    
    December 2020
42. KIM JI, Park S, Bae JY, Lee S, et al
    Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
    PLoS Biol. 2020;18:e3001024.
    PubMed     Abstract available
    
    
    
43. REIJNS MAM, Thompson L, Acosta JC, Black HA, et al
    A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection.
    PLoS Biol. 2020;18:e3001030.
    PubMed     Abstract available
    
    
    November 2020
44. KENNEDY DA, Read AF
    Monitor for COVID-19 vaccine resistance evolution during clinical trials.
    PLoS Biol. 2020;18:e3001000.
    PubMed     Abstract available
    
    
    
45. ALTHOUSE BM, Wenger EA, Miller JC, Scarpino SV, et al
    Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control.
    PLoS Biol. 2020;18:e3000897.
    PubMed     Abstract available
    
    
    
46. ZHOU Y, Hou Y, Shen J, Mehra R, et al
    A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.
    PLoS Biol. 2020;18:e3000970.
    PubMed     Abstract available
    
    
    
47. KADING RC, Kingston T
    Common ground: The foundation of interdisciplinary research on bat disease emergence.
    PLoS Biol. 2020;18:e3000947.
    PubMed     Abstract available
    
    
    October 2020
48. KUDO E, Israelow B, Vogels CBF, Lu P, et al
    Detection of SARS-CoV-2 RNA by multiplex RT-qPCR.
    PLoS Biol. 2020;18:e3000867.
    PubMed     Abstract available
    
    
    
49. BRUCE EA, Huang ML, Perchetti GA, Tighe S, et al
    Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step.
    PLoS Biol. 2020;18:e3000896.
    PubMed     Abstract available
    
    
    
50. KUCHARSKI AJ, Funk S, Eggo RM
    The COVID-19 response illustrates that traditional academic reward structures and metrics do not reflect crucial contributions to modern science.
    PLoS Biol. 2020;18:e3000913.
    PubMed     Abstract available
    
    
    September 2020
51. SELZER L, Su Z, Pintilie GD, Chiu W, et al
    Full-length three-dimensional structure of the influenza A virus M1 protein and its organization into a matrix layer.
    PLoS Biol. 2020;18:e3000827.
    PubMed     Abstract available
    
    
    
52. LIEBERMAN NAP, Peddu V, Xie H, Shrestha L, et al
    In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
    PLoS Biol. 2020;18:e3000849.
    PubMed     Abstract available
    
    
    August 2020
53. KALINICH CC, Jensen CG, Neugebauer P, Petrone ME, et al
    Real-time public health communication of local SARS-CoV-2 genomic epidemiology.
    PLoS Biol. 2020;18:e3000869.
    PubMed     Abstract available
    
    
    
54. GOODSELL DS, Voigt M, Zardecki C, Burley SK, et al
    Integrative illustration for coronavirus outreach.
    PLoS Biol. 2020;18:e3000815.
    PubMed     Abstract available
    
    
    
55. COYNE C, Ballard JD, Blader IJ
    Recommendations for future university pandemic responses: What the first COVID-19 shutdown taught us.
    PLoS Biol. 2020;18:e3000889.
    PubMed     Abstract available
    
    
    June 2020
56. SNIJDER EJ, Limpens RWAL, de Wilde AH, de Jong AWM, et al
    A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis.
    PLoS Biol. 2020;18:e3000715.
    PubMed     Abstract available
    
    
    April 2020
57. MAIA CHAGAS A, Molloy JC, Prieto-Godino LL, Baden T, et al
    Leveraging open hardware to alleviate the burden of COVID-19 on global health systems.
    PLoS Biol. 2020;18:e3000730.
    PubMed     Abstract available
    
    
    June 2019
58. ABDELNABI R, Geraets JA, Ma Y, Mirabelli C, et al
    A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses.
    PLoS Biol. 2019;17:e3000281.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: